Huangpu District announced a new trial policy aimed at increasing equity investment by multinational companies during its foreign investment promotion conference on Thursday.
医思健康 ( 0.79, 0.02, 2.60%) (02138)公布,于2024年11月6日,公司间接全资附属Jade Master International Limited、马智勉及胡润齐拟分别向AIA Hong Kong Medical Services Limited出售New Medical Centre Holding ...